Eli Lilly and Company
PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS
Last updated:
Abstract:
The present invention provides phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds, to pharmaceutical compositions comprising the compounds, to methods of using the compounds to treat physiological disorders such as cancer.
Status:
Application
Type:
Utility
Filling date:
11 Apr 2018
Issue date:
22 Apr 2021